Open official notice

Guidance "秘実S" - Safety alert

Official notice

21 Feb 2019

Last checked

27 Oct 2026

RecallScope risk estimate:HighCAA Japan

An official CAA Japan notice concerns Guidance "秘実S" - Safety alert. Violation of the provisions of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. ■Background: Analysis by the Kawasaki City Institute for Public Health of a so-called health food purchased by Kawasaki City for testing detected tadalafil, a pharmaceutical ingredient used to treat erectile dysfunction and other conditions. This product containing tadalafil qualifies as a pharmaceutical under Article 2, paragraph 1 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter the "Pharmaceuticals and Medical Devices Act"). Selling this product violates Article 55, paragraph 2 of that Act (prohibition on the sale, supply, etc. of unapproved and unlicensed pharmaceuticals). Published 2019-02-21.

What to do now

■Kawasaki City's response: We are instructing the store where the product was purchased to recall the product and take other measures. We have also asked the Tokyo Metropolitan Government, which has jurisdiction over the seller, to provide guidance and take measures concerning the violation of the Pharmaceuticals and Medical Devices Act. We will post information about the product on the city's website to alert the public.

Official notice

2019-02-21

The hazard

Violation of the provisions of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. ■Background: Analysis by the Kawasaki City Institute for Public Health of a so-called health food purchased by Kawasaki City for testing detected tadalafil, a pharmaceutical ingredient used to treat erectile dysfunction and other conditions. This product containing tadalafil qualifies as a pharmaceutical under Article 2, paragraph 1 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter the "Pharmaceuticals and Medical Devices Act"). Selling this product violates Article 55, paragraph 2 of that Act (prohibition on the sale, supply, etc. of unapproved and unlicensed pharmaceuticals).

How to check if you're affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Best Before Dates

10 AUG 2021

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

秘実S

Hazard

Violation of the provisions of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. ■Background: Analysis by the Kawasaki City Institute for Public Health of a so-called health food purchased by Kawasaki City for testing detected tadalafil, a pharmaceutical ingredient used to treat erectile dysfunction and other conditions. This product containing tadalafil qualifies as a pharmaceutical under Article 2, paragraph 1 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter the "Pharmaceuticals and Medical Devices Act"). Selling this product violates Article 55, paragraph 2 of that Act (prohibition on the sale, supply, etc. of unapproved and unlicensed pharmaceuticals).

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

JP · Japan

Affected area 1

JP · Japan

Company & contacts

Brand

ガイダンス

Manufacturer

株式会社ガイダンス 東京都港区浜松町1-6-2丸神ビル4F

Phone

Not provided

Brand: ガイダンス. Contact: 【注意喚起】.

Source & status

Source

Tier

official

Category

FOOD

Official classification

消費者庁 — 注意喚起

Recall details

Event id

CAA-00000022142

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 21 Feb 2019. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button